HYDERABAD: After AstraZeneca’s admitted in a UK court that its Covid-19 vaccine caused a rare side-effect — Thrombosis with Thrombocytopenia Syndrome (TTS),...
The painless, non-invasive and needleless vaccine was officially launched by the Union Health Ministry on Republic Day but is yet to be...
In December, Hyderabad-based company Bharat Biotech announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by...
Bhopal: The nasal Covid-19 vaccine from Bharat Biotech, known as the iNCOVACC, is anticipated to be on sale on January 26. Executive...
Asingle dose of Bharat Biotech’s intranasal vaccine iNCOVACC, which was approved for inclusion into India’s Covid-19 immunisation programme last week, will cost...
Amid a sharp uptick in demand for the precautionary vaccine dose in the country since last week, the Union Health Ministry has approved Bharat...
Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to...
Hyderabad: Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has...
The booster dose of Bharat Biotech’s Covid-19 nasal vaccine iNCOVACC on Friday received emergency use authorisation (EUA) from the Drugs Controller General...
Bharat Biotech International Ltd (BBIL) on Tuesday got emergency use authorisation from DCGI for intranasal COVID-19 vaccine, announced Union Health Minister Mansukh...